Skip to main content
Mediastinal relapse risk lower with PORT, but no survival benefit
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Mediastinal relapse risk lower with PORT, but no survival benefit
User login
Username
Password
Reset your password
Specialty
Lead
score
Hematology-Oncology
1
1
Internal Medicine
0
0.9
Concept
Lead
score
Lung Cancer
0
1
Toxicology
0
0.77
Metastasis
0
0.62
Non-Small Cell Lung Cancer
0
0.99
Small Cell Lung Cancer
0
0.58
Cancer
0
0.56
Resection
0
0.34
Tumor
0
0.34
Lung
0
0.23
Lymph Node
0
0.23
Postoperative
0
0.23
Radiation Therapy
0
0.23
Adjuvant Chemotherapy
0
0.16
Brachial
0
0.11
Chemotherapy
0
0.11
Clinical Research
0
0.11
Europe
0
0.11
Hospital
0
0.11
Neoadjuvant Therapy
0
0.11
UK Site Content
0
0.11